ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

Uncovering Mechanisms Associated With ADT Resistance in Prostate Cancer

Uncovering Mechanisms Associated With ADT Resistance in Prostate Cancer

In this video, David Goodrich, PhD, of Roswell Park Cancer Institute in Buffalo, discusses treatment resistance and disease relapse in prostate cancer.

Dr. Goodrich presented the possible underlying mechanisms associated with androgen deprivation therapy (ADT) resistance and suggests an epigenetic approach for extending the clinical benefits of ADT at the 2017 American Society for Cancer Research (AACR) Annual Meeting, held April 1–5 in Washington, DC.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.